patient
|
2-S22 |
Age
|
28 |
Dose(mg)
|
1 |
Cervical lesion size
|
<50% |
V1(Histology)
|
CIN3 |
V1 (HPV)
|
16 |
V7(Histology)
|
NIL |
V7 (HPV)
|
Neg |
V7 histopatholgic regression
|
Yes |
V7 HPV clearance
|
Yes |
V8(Histology)
|
NIL |
V8 (HPV)
|
Neg |
V8 histopatholgic regression
|
Yes |
V8 HPV Clearance
|
Yes |
Included in V7 (20weeks after 1st injection)analysis
|
Yes |
Included in V8 (36weeks after 1st injection) analysis
|
Yes |
HPV nucleotide sequencing
|
Yes |